about
Synthesis of lipid mediators during UVB-induced inflammatory hyperalgesia in rats and miceEmerging roles of resolvins in the resolution of inflammation and painPro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in InflammationRole of central and peripheral opiate receptors in the effects of fentanyl on analgesia, ventilation and arterial blood-gas chemistry in conscious ratsAncient Chinese medicine and mechanistic evidence of acupuncture physiologyManagement of painful wounds in advanced disease.The role of kappa-opioid receptor activation in mediating antinociception and addiction.Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors.Sustained morphine-mediated pain sensitization and antinociceptive tolerance are blocked by intrathecal treatment with Raf-1-selective siRNA.Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development.Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.Synthesis and pharmacological activities of 6-glycine substituted 14-phenylpropoxymorphinans, a novel class of opioids with high opioid receptor affinities and antinociceptive potencies.Stress-induced allodynia--evidence of increased pain sensitivity in healthy humans and patients with chronic pain after experimentally induced psychosocial stress.Responses of spinal dorsal horn neurons to foot movements in rats with a sprained ankle.Neural correlates of an injury-free model of central sensitization induced by opioid withdrawal in humans.Dynamic temporal and spatial regulation of mu opioid receptor expression in primary afferent neurons following spinal nerve injury.Effect of pulsed electromagnetic field treatment on programmed resolution of inflammation pathway markers in human cells in culture.Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipationThe delta opioid receptor: an evolving target for the treatment of brain disorders.Genetics and Gene Expression Involving Stress and Distress Pathways in Fibromyalgia with and without Comorbid Chronic Fatigue Syndrome.Assessment of an Orofacial Operant Pain Assay as a Preclinical Tool for Evaluating Analgesic Efficacy in RodentsAcute morphine induces matrix metalloproteinase-9 up-regulation in primary sensory neurons to mask opioid-induced analgesia in mice.Evoked pain analgesia in chronic pelvic pain patients using respiratory-gated auricular vagal afferent nerve stimulationActivation of endogenous opioid gene expression in human keratinocytes and fibroblasts by pulsed radiofrequency energy fieldsMechanisms of the antinociceptive action of (-) epicatechin obtained from the hydroalcoholic fraction of Combretum leprosum Mart & Eic in rodentsDelta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.LncRNA uc.48+ is involved in diabetic neuropathic pain mediated by the P2X3 receptor in the dorsal root ganglia.Activation of Peripheral μ-opioid Receptors by Dermorphin [D-Arg2, Lys4] (1-4) Amide Leads to Modality-preferred Inhibition of Neuropathic PainFunctional role of peripheral opioid receptors in the regulation of cardiac spinal afferent nerve activity during myocardial ischemia.Receptor and channel heteromers as pain targets.Sustained morphine treatment augments capsaicin-evoked calcitonin gene-related peptide release from primary sensory neurons in a protein kinase A- and Raf-1-dependent manner.Effective gene expression in the rat dorsal root ganglia with a non-viral vector delivered via spinal nerve injection.Tolerance develops to the antiallodynic effects of the peripherally acting opioid loperamide hydrochloride in nerve-injured rats.Aryl-1,3,5-triazine ligands of histamine H4 receptor attenuate inflammatory and nociceptive response to carrageen, zymosan and lipopolysaccharide.The search for novel analgesics: re-examining spinal cord circuits with new toolsLoss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia.Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain.Update on peripheral mechanisms of pain: beyond prostaglandins and cytokines.Should topical opioid analgesics be regarded as effective and safe when applied to chronic cutaneous lesions?Possible sites of therapeutic action in restless legs syndrome: focus on dopamine and α2δ ligands.
P2860
Q21132412-2AC05004-DCC7-4768-9F85-92B1C93D2A1FQ28249435-C22E83E1-D82C-49A6-B653-DB27E435326DQ28716294-94FF2545-F601-40CB-B476-3478BB45E191Q30405854-B5C6E619-03E5-4193-A763-6DC0A73E8D21Q30473618-E42C541A-2707-456B-BDF8-356D7E01EB40Q34126092-7116415F-5662-4B2A-86AC-6CEF93D013E7Q34132638-75275206-37AE-40BA-A5D7-958B1A368561Q34219916-152B18F4-DCBB-4FA9-BE20-2D32899651F4Q34233899-2E56A871-CF54-4367-9029-7426B11E7458Q34376548-A1F1DA68-E22B-4DC8-AE95-7885209F3F8AQ34385062-CBFA8AE2-F07D-4049-B4C3-1239EC4360EEQ34583511-968D1FC4-8566-4702-826E-E7A3F5AC1FABQ34946334-A4D0E3AB-E5A2-42F3-9CCB-40D03A0EF675Q34980181-FD83D8D5-D326-400B-A63C-0F234813452BQ34982888-729A4DC2-A145-4189-AEEF-736A6B853C39Q35085646-7233C804-AD70-415A-AE3E-7C2988D1E53DQ35137287-EE39E423-0C9A-4EBC-939B-B04554C3F9B7Q35174654-BEB2EAEF-F25C-4DD4-B72B-0486BE19F85DQ35400738-7BEFC422-1AC1-4C2B-9016-A087CDCD5D44Q35431288-DB5BD776-3C95-4E2F-8B69-93904D33E43EQ35906905-75631D37-73F7-459C-AA86-61C08F26319EQ35963214-19D96B63-7ABA-4080-ACFC-36E0D5C2344FQ36035597-F98B3415-C3F5-438B-8D0F-E7D8C0E365A9Q36289342-882229A1-C939-44ED-BA2B-2967939BB3DBQ36406600-AABEE850-1F0B-425F-B62A-E7D5AD20F8F9Q36438816-E5C0634B-7882-4CFC-A475-A09D535D3DFBQ36568444-113B0438-DE8D-45DA-98F1-A8AB3140F48EQ36586274-30DD3B38-6A43-41EB-A378-DFB6F3A6917AQ37054959-642BDBFD-0828-43AD-AC64-AED1C5BC6994Q37148710-8CC31987-90C2-4D77-8C70-9000ABA7CCA6Q37312862-5D7F067A-D97C-4432-B17C-2AAEBD00406BQ37343097-36D70013-13D9-4AFA-A1B7-103A7881C342Q37394103-52CC63E5-1491-4431-A379-3E565C661CE0Q37553620-0AB9A6C7-6378-4705-95BC-0AEB091B7BA1Q37602458-F58C3341-E60A-4DB7-AF96-9C5E05EAB1C5Q37629809-527D678C-6EAC-4274-94AE-B417578A265DQ37638416-39889D63-CBD1-4440-83D4-B7AFDEA10AD3Q37872045-339F6F4B-323E-4111-B64B-C44606EF9884Q37876457-AD066D06-0ACC-4B54-991A-27B2922DAEDAQ37895053-56B241F4-A8C6-433B-AD4E-86E8A85EA48C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Peripheral mechanisms of pain and analgesia.
@en
Peripheral mechanisms of pain and analgesia.
@nl
type
label
Peripheral mechanisms of pain and analgesia.
@en
Peripheral mechanisms of pain and analgesia.
@nl
prefLabel
Peripheral mechanisms of pain and analgesia.
@en
Peripheral mechanisms of pain and analgesia.
@nl
P2093
P2860
P1476
Peripheral mechanisms of pain and analgesia.
@en
P2093
Aaron C Overland
George L Wilcox
J David Clark
Michael R Vasko
Robert H Spencer
Todd W Vanderah
P2860
P304
P356
10.1016/J.BRAINRESREV.2008.12.017
P577
2008-12-31T00:00:00Z